FDA Inspection 1046331 — Bausch Health US., LLC.
The FDA completed an inspection of Bausch Health US., LLC. on February 28, 2018 in Bridgewater, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 28, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bridgewater, NJ (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)